Japan Allows Pfizer, Sanofi To Resume Vaccine Marketing
This article was originally published in PharmAsia News
Executive Summary
Japanese authorities cleared U.S.-based Pfizer Inc. and France's Sanofi-Aventis to resume marketing a pair of vaccines in Japan